NVTA Invitae Corp

Invitae Corp is a genetic information company engaged in genetic diagnostics for hereditary disorders. It provides testing for multiple genes including hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions.

$28.40  +0.22 (0.78%)
As of 07/26/2021 10:12:31 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2015
Outstanding shares:  199,837,259
Average volume:  2,563,622
Market cap:   $5,675,378,156
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    46185L103
ISIN:        US46185L1035
Sedol:      BVVCNT1
Valuation   (See tab for details)
PE ratio:   -9.18
PB ratio:   2.34
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy